Ben Lamm

Ben Lamm

Colossal Spinout Astromech Acquires Sister Company Form Bio for $230M

by | Nov 17, 2026
The all-stock deal brings together two Dallas companies, pairing Astromech’s evolutionary AI models with Form Bio’s tools for designing genetic medicines. Form Bio co-founder Andrew Busey becomes Astromech’s chief AI officer.
MORE►
Dodo render
Dallas’ Colossal Biosciences Unveils AI Platform to Help Revive the Dodo Bird
by | Oct 14, 2026
The Dallas-based de-extinction company said its GenoMorph platform continues a series of breakthroughs aimed at reviving extinct and endangered species.
MORE►
Dallas’ Colossal Foundation Joins IUCN in $4M ‘Race Against Time’ Effort to Prevent Extinction
by | Sep 17, 2026
The foundation and IUCN Species Survival Commission have launched a four-year partnership that will use Colossal Biosciences’ technology to improve tracking of endangered species, including overlooked fungi, plants, invertebrates, fishes and reptiles.
MORE►
Colossal Tasmanian devil facial tumor.

Colossal Foundation Partners with the University of Tasmania to ‘Give Tasmanian Devils a Fighting Chance’

by | Jul 7, 2026
By using a vaccine and gene editing, the partners aim to fight a lethal cancer that has reduced the wild population of Tasmanian devils by 80% since the 1990s.
MORE►
Dallas-Based Colossal and U.S. Fish and Wildlife Service Launch BioVault Initiative for Endangered Species
by | Jun 25, 2026
"By preserving the genetic blueprint of every endangered species in America, we're creating a living archive of Earth's biodiversity—a modern-day Noah's Ark built from DNA and a permanent genetic backup of our nation's most imperiled species," said Colossal Biosciences Co-Founder and CEO Ben Lamm.
MORE►
Colossal Hatches Chicks, Cracks the Egg Problem for Giant Bird De‑Extinction
The Dallas biotech says the shell-less incubation platform could help revive species such as the South Island Giant Moa, whose massive eggs exceed the capacity of any living bird surrogate.
MORE►
Colossal Targets Extinct Antelope—and Adds a New Branch to its De-Extinction ‘Tree of Life’
by | Apr 30, 2026
At a $10 billion valuation—and spinning out new ventures—Colossal names the bluebuck its sixth de-extinction target, extending its biotech platform into antelope conservation through a global BioVault effort.
MORE►

Colossal Foundation Reaches $100M as Its 2025 Impact Report Spans AI-Decoded Wolf Howls to Keeping Species Off the Extinction List

by | Dec 17, 2025
Dallas-based Colossal Biosciences’ nonprofit arm has doubled its funding to $100 million and released its first Impact Report as it puts technology to work from Yellowstone to the Texas Gulf Coast—and beyond.
MORE►
‘There’s So Much Energy in Our Space’: Innovators, Investors Invigorate Sold-Out 2025 Venture Dallas Conference
by | Nov 5, 2025
From North Texas founders including John Carmack and Ben Lamm to investors like John Redgrave of DTX Ventures and Draper’s Andy Tang, the summit's speakers tackled hot topics from humanoid robots and tech transfer to AI, VC trends and Y’all Street. A call was also heard for more risk-taking by DFW’s innovation ecosystem: ‘We’ve got to be bravery hunters.’
MORE►

AGI and De-Extinction: John Carmack and Ben Lamm Join Venture Dallas 2025 Lineup

by | Aug 26, 2025
Set for Oct. 30 at the George W. Bush Presidential Center, this year's Venture Dallas conference will assemble more than 500 entrepreneurs, investors, and business leaders for a day of transformative ideas and connections.
MORE►
Colossal Biosciences Names Australian De‑Extinction Scientist as Its Chief Biology Officer
by | Aug 20, 2025
Andrew Pask is known for his expertise in de-extinction science, developmental genetics, and conservation technologies. He leads the Thylacine Integrated Genomic Restoration Research Lab (TIGGR) at the University of Melbourne in Australia.
MORE►
The South Island giant moa towered over New Zealand's forests for millions of years before becoming extinct within a century of Polynesian settlement around 1400 CE. Colossal Biosciences plans to resurrect the 500-pound birds using ancient DNA extracted from cave deposits and artificial egg technology. [Source image: Colossal Biosciences]
Colossal Biosciences Takes On De‑Extinction of New Zealand’s 12‑Foot Moa After Dire Wolf Milestone
by | Jul 9, 2025
The Dallas decacorn is scaling its de-extinction pipeline with indigenous leadership, a New Zealand subsidiary, and economic models for species preservation, including ecotourism opportunities. Filmmaker Sir Peter Jackson helped connect the collaborators, Colossal CEO Ben Lamm says.
MORE►
TIME’s 2025 covers feature star power—with Ryan Reynolds of Maximum Effort and Waymo’s co-CEOs front and center. But the list also includes standout innovation coming straight out of Dallas.
Two Dallas Companies Land on TIME100 Most Influential—Alongside the World’s Biggest Brands
by | Jun 26, 2025
While TIME put Maximum Effort and Waymo on its 2025 worldwide covers, Dallas future-shaping companies are in the mix. Two are Dallas-based. Another Texas company—now a $2B brand—got its start here, too.
MORE►